在多发性硬化症中测定萨卡德异常的评估,使用一种新的临床萨卡多米测试
Zahra Polat1,2, Ahmet Alperen Akbulut1,3, Sema Satıcı1,3
1Department of Audiology, Hamidiye Faculty of Health Sciences, University of Health Sciences, Istanbul, Turkey.
Audiology & neuro-otology
|June 4, 2025
概括
赛卡多米测试揭示了多发性硬化症 (MS) 患者眼动控制的显著差异. 这些发现表明,分支测量可以帮助诊断神经退行性疾病,如MS.
科学领域:
- 神经科学是一个神经科学.
- 眼科医生 眼科 眼科
- 神经学 神经学
背景情况:
- 萨卡多米是一项眼部运动测试,用于评估大脑中参与萨卡迪眼动的区域.
- 这种测试对脑震荡和神经退行性疾病敏感.
- 复发性复发性硬化症 (RRMS) 影响神经功能,可能会影响眼睛的运动.
研究的目的:
- 为了比较健康个体和RRMS患者之间的萨卡多米表现.
- 评估RRMS患者的前冲动和反冲动表现.
- 为了确定是否可以分辨MS患者与对照者的分离.
主要方法:
- 32名RRMS患者 (18-60岁) 和28名健康对照参与了研究.
- 参与者接受了视频阴影影像 (VNG) 测试电池,包括度测量.
- 测试包括自发性阴影,凝视,随机冲刺,追逐和光动力学评估.
主要成果:
- 在多发性硬化症组中,前冲动和反冲动的延迟时间显著延长.
- 在MS患者和对照人群之间,方向错误率显著不同.
- 两组之间在随机冲击延迟,峰值速度或准确度方面没有发现显著差异.
结论:
- 与健康个体相比,多发性硬化症患者的眼球运动控制显著差异.
- 临床度测试是评估神经退行性疾病的宝贵,非侵入性工具.
- 建议将分泌体测量纳入前庭测试电池中,用于MS等疾病.
相关概念视频
Multiple Comparison Tests
Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...


